Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma

Clinical and Experimental Dermatology

Volumn 32, Issue 4, 2007, Pages 405-416

  Brezillon S ^a,b   Venteo, L ^a   Ramont, L ^a   D'Onofrio, M F ^a   Perreau, C ^a   Pluot, M ^a   Maquart, F X ^a   Wegrowski, Y ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; LUMICAN; PROTEOGLYCAN;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DERMIS; FEMALE; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATAN SULFATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; STROMAL CELLS;

EID: 34249673940     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02437.x     Document Type: Article

References (25)

1. Ruiter D, Bogenrieder T, Elder D et al. Melanoma-stroma interactions. structural and functional aspects. Lancet Oncol 2002 3 : 35 43.
2. Iozzo RV. Matrix proteoglycans from molecular design to cellular function. Annu Rev Biochem 1998 67 : 609 52.
3. Schönherr E, Sunderkötter C, Schaefer L et al. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 2004 41 : 499 508.
4. Carrino DA, Onnerfjord P, Sandy JD et al. Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem 2003 278 : 17566 72.
5. Vuillermoz B, Khoruzhenko A, D'Onofrio MF et al. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 2004 296 : 294 306.
6. Vuillermoz B, Wegrowski Y, Contet-Audonneau JL et al. Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol Cell Biochem 2005 277 : 63 72.
7. Kao WW-Y, Funderburgh JL, Xia Y et al. Focus on molecules: lumican. Exp Eye Res 2006 82 : 3 4.
8. Chakravarti S, Magnuson T, Lass JH et al. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998 141 : 1277 86.
9. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 1990 346 : 821 4.
10. Danielson KG, Baribault H, Holmes DF et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997 136 : 729 43.
11. De Luca A, Santra M, Baldi A et al. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinase. J Biol Chem 1996 271 : 18961 5.
12. Patey M, Delemer B, Bellon G et al. Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours. J Clin Pathol 1999 52 : 895 900.
13. Karjalainen JM, Eskelinen MJ, Nordling S et al. Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. Br J Cancer 1998 77 : 1917 25.
14. Iozzo RV, Moscatello DK, McQuillan DJ et al. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999 274 : 4489 92.
15. Santra M, Mann DM, Mercer EW et al. Ectopic expression of decorin protein core causes a generalized growth suppresion in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 1997 100 : 149 57.
16. Vij N, Roberts L, Joyce S et al. Lumican regulates corneal inflammatory responses by modulating fas-fas ligand signaling. Invest Ophthalmol Vis Sci 2005 46 : 88 97.
17. Funderburgh JL, Mitschler RR, Funderburgh ML et al. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest Ophthalmol Vis Sci 1997 38 : 1159 67.
18. Tran KT, Lamb B, Deng JS et al. Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Derm Sci 2005 40 : 11 20.
19. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 19 : 3635 48.
20. Shinji S, Tajiri T, Ishiwata T et al. Different expression levels of lumican in human carcinoid tumor and neuroendocrine cell carcinoma. Int J Oncol 2005 26 : 873 80.
21. Seya T, Tanaka N, Shinji S et al. Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol Rep 2006 16 : 1225 30.
22. Naito Z. The role of small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J Nippon Med Sch 2005 72 : 137 45.
23. Honda E, Munakata H. Purification and characterization of decorin from the culture media of MRC-5 cells. Int J Bioch Cell Biol 2004 36 : 1635 44.
24. Sifaki M, Assouti M, Nikitovic D et al. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 2006 58 : 606 10.
25. Hart IR, Birch M, Marshall JF. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 1991 10 : 115 28.